BioNTech and Roche to present new cancer drug data at ESMO 2026
BioNTech plans to present 16 oncology abstracts at ESMO 2026, including Phase 2 data on pumitamig combinations in advanced cancers and a trial of pumitamig plus docetaxel for metastatic lung cancer. Roche’s Genentech will present late-stage findings on divarasib in KRAS G12C-mutated lung cancer, giredestrant in breast cancer and its experimental Tam-Peli therapy.
Health · 7 sources · Oct 19, 2026Read it
The journal
Open the journal →The conversation starts in the journal — be the first to post.
About Genentech
Genentech, Inc. is an American biotechnology corporation headquartered in South San Francisco, California. It operates as an independent subsidiary of holding company Roche. Genentech Research and Early Development operates as an independent center within Roche. Historically, the company is regarded as the world's first biotechnology company.
Everything about Genentech →- Country
- United States
- Headquarters
- South San Francisco
- Inception
- 1976, April 7, 1976
- Website
- http://www.gene.com/